Lambda published research on an AI approach called EGInterpolator designed to scale molecular dynamics (MD) simulations for drug discovery1. The work addresses limitations of static structure prediction and molecular docking, which provide only snapshots of drug-protein interactions. MD simulations model how drug-target interactions behave over time, including interaction stability, protein shape changes, and molecular system evolution. The research was detailed on Lambda's official blog.
Lambda Publishes AI Molecular Dynamics Research for Drug Discovery
Lambda detailed research on EGInterpolator, an AI approach to scaling molecular dynamics simulations for drug discovery, on its official blog.